Latest news
TOPAZ-1 Post Hoc Analysis Supports Durvalumab Plus Chemotherapy in Advanced Biliary Tract Cancer - The ASCO PostThe ASCO Post · Tue, 04 Aug 2026 13:59:48 GMTRucaparib plus nivolumab maintenance did not meet 4-month PFS target in advanced biliary tract cancer - Vera HealthVera Health · Sun, 02 Aug 2026 09:15:29 GMTImfinzi Combo Cuts Risk of Death by 25% in Advanced Biliary Tract Cancer - Cure TodayCure Today · Fri, 31 Jul 2026 16:36:43 GMTLeads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Completes Patient Enrollment in Phase II Study for Biliary Tract Cancer, Further Demonstrating Breakthrough Potential in Immune-Cold Tumors - The Manila TimesThe Manila Times · Thu, 30 Jul 2026 10:40:18 GMT